Bosque Farms, NM, United States of America

Greg A Volkmer


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 279(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in DNA Sequencing by Greg A. Volkmer

Introduction

Greg A. Volkmer is an accomplished inventor based in Bosque Farms, New Mexico. He is known for his significant contributions to the field of genetic research, particularly in the area of DNA sequencing. With a focus on developing efficient methods for genomic sequencing, Volkmer has made strides that could impact various applications in biotechnology and medicine.

Latest Patents

Volkmer holds a patent for "Methods of amplifying and sequencing nucleic acids." This invention provides an apparatus and method for performing rapid DNA sequencing, including genomic sequencing. The method involves preparing a sample DNA for genomic sequencing, amplifying the prepared DNA in a representative manner, and conducting multiple sequencing reactions on the amplified DNA with only one primer hybridization step. This innovative approach enhances the efficiency and speed of DNA sequencing processes.

Career Highlights

Throughout his career, Greg A. Volkmer has been associated with 454 Life Sciences Corporation, a company known for its advancements in DNA sequencing technologies. His work has contributed to the development of tools that facilitate genetic research and diagnostics. Volkmer's expertise in the field has positioned him as a valuable asset in the biotechnology sector.

Collaborations

Volkmer has collaborated with notable colleagues, including John Harris Leamon and Keith McDade. These partnerships have fostered an environment of innovation and have led to the advancement of technologies in DNA sequencing.

Conclusion

Greg A. Volkmer's contributions to the field of DNA sequencing exemplify the impact of innovative thinking in biotechnology. His patent for methods of amplifying and sequencing nucleic acids represents a significant advancement in the efficiency of genomic sequencing. Through his work at 454 Life Sciences Corporation, Volkmer continues to influence the future of genetic research and its applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…